Capital Flow Monitor · Sponsors · CIK 1673368
DalCor Pharmaceuticals US, LLC
677 North Washington Blvd, Sarasota, FL, 34236 · 514 508-5099
Pharmaceuticals · Limited Liability Company· inc. DELAWARE true
Fit score
—
Offering
$7.0M
Sold
$7.0M
% sold
100.0%
Investors
8
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-28 | D ·current | 506(b) | $7.0M | $7.0M | 100.0% | 8 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Douglas Michael Dixon — Director, Sarasota, FL
-
Paul Fonteyne — Director, Sarasota, FL
3 other raises
- Allyx Therapeutics, Inc. $26.4M of $30.0M · 88.1%
- Apnimed, Inc. $35.0M of $35.0M · 100.0%
- Triton Therapeutics, Inc. $36.4M of $36.4M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.